Weight Management
MOTS-c
10 MG · Research Peptide
$69.00
A mitochondrial-derived peptide investigated in research on cellular metabolism and energy homeostasis.
- 10 mg lyophilized powder per vial
- ≥ 98% purity, HPLC verified
- Batch tested for identity and potency
- For laboratory research use only
View MOTS-C batch Certificates of AnalysisMOTS-c research guideRP-HPLC purity standards guideMass spectrometry testing guideStorage and refrigeration guideReconstitution guideGlossary of analytical terms
Research use only. Not for human consumption.
What is MOTS-c?
MOTS-c is a 16-amino-acid peptide encoded by the mitochondrial 12S rRNA gene, commonly investigated in preclinical metabolic research. It is not approved by the FDA as a therapeutic drug.
| Sequence | Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (MRWQEMGYIFYPRKLR) |
|---|---|
| Length | 16 amino acids |
| Molecular formula | C101H115N25O20S2 |
| Molecular weight | 2174.6 g/mol (average) |
| CAS number | 1627580-64-7 |
| Purity specification | ≥ 98.0% by RP-HPLC |
| Research status | Preclinical and in-vitro research compound. No FDA-approved indication; not an approved medicine in the United States. |
| Analytical methods | Reversed-phase HPLC (RP-HPLC) for purity and mass spectrometry (MS) for identity confirmation, reported per lot. |
| Available COA | Lot-specific Certificates of Analysis are published in the Vector E Lab COA library under the product name MOTS-C. View published certificates |
| Regulatory context | Supplied for Research Use Only (RUO) — in-vitro laboratory research and analytical testing by qualified personnel. Not for human or veterinary use, not for diagnostic procedures, and not a therapeutic product. |
| References |
Analytical specifications
| Purity (RP-HPLC) | ≥ 98.0% by reversed-phase HPLC |
|---|---|
| Fill quantity | 10 MG lyophilized powder per vial |
| Category | Weight Management |
| Intended use | Research Use Only (RUO) — in-vitro laboratory research |
Batch Certificates of Analysis
| Batch number | Strength | Testing date | Certificate |
|---|---|---|---|
| SD-260730-1 | 40mg | 2026-08-10 | View COA (PDF) |
Frequently asked questions
- What is MOTS-c?
- MOTS-c is a 16-amino-acid peptide encoded by the mitochondrial 12S rRNA gene, commonly investigated in preclinical metabolic research. It is not approved by the FDA as a therapeutic drug. Sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (MRWQEMGYIFYPRKLR). Molecular weight: 2174.6 g/mol (average). CAS number: 1627580-64-7. Research status: Preclinical and in-vitro research compound. No FDA-approved indication; not an approved medicine in the United States. Analytical methods: Reversed-phase HPLC (RP-HPLC) for purity and mass spectrometry (MS) for identity confirmation, reported per lot.
- What is the purity of MOTS-c?
- MOTS-c is released at ≥ 98.0% purity as determined by reversed-phase HPLC (RP-HPLC). Purity is reported per lot on the batch Certificate of Analysis.
- Is a Certificate of Analysis available for MOTS-c?
- Yes. One published batch is listed on this page with batch number, strength, testing date and a downloadable COA PDF. Every certificate is also available in the Vector E Lab COA library.
- How is MOTS-c supplied?
- Each vial contains 10 MG of lyophilized powder, supplied in the Weight Management research category for in-vitro laboratory work.
- Can MOTS-c be used in humans or animals?
- No. MOTS-c is supplied strictly for Research Use Only (RUO) — in-vitro laboratory research and analytical testing by qualified laboratory personnel. It is not for human or veterinary use, diagnostic procedures, or therapeutic administration.
Related research peptides
